IRIS Accounts Production v24.3.2.46 08102279 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh081022792023-06-30081022792024-06-30081022792023-07-012024-06-30081022792022-06-30081022792022-07-012023-06-30081022792023-06-3008102279ns15:EnglandWales2023-07-012024-06-3008102279ns14:PoundSterling2023-07-012024-06-3008102279ns10:Director12023-07-012024-06-3008102279ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3008102279ns10:Micro-entities2023-07-012024-06-3008102279ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3008102279ns10:FullAccounts2023-07-012024-06-3008102279ns5:CurrentFinancialInstruments2024-06-3008102279ns5:CurrentFinancialInstruments2023-06-3008102279ns10:RegisteredOffice2023-07-012024-06-30081022791ns10:Director12023-06-30081022791ns10:Director12022-06-30081022791ns10:Director12023-07-012024-06-30081022791ns10:Director12022-07-012023-06-30081022791ns10:Director12024-06-30081022791ns10:Director12023-06-30
REGISTERED NUMBER: 08102279 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

MG Toxicology Consulting Ltd

MG Toxicology Consulting Ltd (Registered number: 08102279)






Contents of the Financial Statements
for the Year Ended 30 June 2024




Page

Balance Sheet 1


MG Toxicology Consulting Ltd (Registered number: 08102279)

Balance Sheet
30 June 2024

30.6.24 30.6.23
£    £   
FIXED ASSETS 1,760 -

CURRENT ASSETS 522,020 507,225

PREPAYMENTS AND ACCRUED INCOME 220 200

CREDITORS
Amounts falling due within one year (33,819 ) (15,388 )
NET CURRENT ASSETS 488,421 492,037
TOTAL ASSETS LESS CURRENT
LIABILITIES

490,181

492,037

ACCRUALS AND DEFERRED INCOME (2,430 ) (2,330 )
NET ASSETS 487,751 489,707

CAPITAL AND RESERVES 487,751 489,707

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

MG Toxicology Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08102279

Registered office: Advanced Technology Innovation Centre
LUSEP
5 Oakwood Drive
Loughborough
Leicestershire
LE11 3QF

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

30.6.24 30.6.23
£    £   
M J Graham BSc, PhD
Balance outstanding at start of year 50,168 11,344
Amounts advanced 505 89,821
Amounts repaid (37,455 ) (50,997 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 13,218 50,168

MG Toxicology Consulting Ltd (Registered number: 08102279)

Balance Sheet - continued
30 June 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued

The loan was repayable on demand and interest has been charged at the HMRC Official Rate.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 24 March 2025 and were signed on its behalf by:





M J Graham BSc, PhD - Director